An Invited Editorial
Is there an overlap between Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy/dysplasia?

https://doi.org/10.1016/j.jelectrocard.2005.03.009Get rights and content

Abstract

The Brugada syndrome is a congenital syndrome displaying an autosomal dominant mode of transmission in patients with a structurally normal heart. The disease has been linked to mutations in SCN5A, a gene located on the short arm of chromosome 3 (p21-24) that encodes for the α subunit of the sodium channel. The syndrome is characterized by a dynamic ST-segment elevation (accentuated J wave) in leads V1 to V3 of the ECG followed by negative T wave. Right bundle-branch block of varying degrees is observed in some patients. The syndrome is associated with syncope and a relatively high incidence of sudden cardiac death secondary to the development of polymorphic ventricular tachycardia that may degenerate into ventricular fibrillation. An acquired form of the Brugada syndrome is also recognized, caused by a wide variety of drugs and conditions that alter the balance of currents active during the early phases of the action potential. Among patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia, there is a subpopulation with a clinical and electrocardiographic pattern similar to that of the Brugada syndrome. These cases of arrhythmogenic right ventricular cardiomyopathy/dysplasia are thought to represent an early or concealed form of the disease. This review examines the overlap between these 2 syndromes.

References (40)

  • A. Elsasser et al.

    Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death

    J Am Coll Cardiol

    (2004)
  • P. Brugada et al.

    A distinct clinical and electrocardiographic syndrome: right bundle branch block, persistent ST segment elevation with normal QT interval and sudden cardiac death

    Pacing Clin Electrophysiol

    (1991)
  • F. Nacarella

    Malignant ventricular arrhythmias in patients with a right bundle branch block and persistent ST segment elevation in V1-V3: a probable arrhythmogenic cardiomyopathy of the right ventricle

    G Ital Cardiol

    (1993)
  • P. Brugada et al.

    Do not get confused, please

    G Ital Cardiol

    (1993)
  • B. Martini et al.

    1988-2003. Fifteen years after the first Italian description by Nava-Martini-Thiene and colleagues of a new syndrome (different from the Brugada syndrome?) in the Giornale Italiano di Cardiologia: do we really know everything on this entity?

    Ital Heart J

    (2004)
  • C. Antzelevitch et al.

    Brugada syndrome a decade of progress

    Circ Res

    (2002)
  • T. Ohe

    Idiopathic ventricular fibrillation of the Brugada type: an atypical form of arrhythmogenic right ventricular cardiomyopathy?

    Intern Med

    (1996)
  • C.R. Bezzina et al.

    Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system

    Circ Res

    (2003)
  • W.P. McNair et al.

    SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia

    Circulation

    (2004)
  • F. Ahmad et al.

    Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23

    Circulation

    (1998)
  • Cited by (29)

    • Risk stratification of patients with Brugada syndrome: the impact of myocardial strain analysis using cardiac magnetic resonance feature tracking

      2021, Hellenic Journal of Cardiology
      Citation Excerpt :

      These abnormalities are commonly considered as characteristics of ARVC.17 There seems to be an overlap between the two diseases, but it remains unclear whether a link exists.22 Particularly in patients with BrS with an sECG, ARVC-typical changes seem to occur more frequently, such as even the detection of fibro-fatty replacement.23

    • Clinical Diagnosis, Imaging, and Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: JACC State-of-the-Art Review

      2018, Journal of the American College of Cardiology
      Citation Excerpt :

      J-point elevation >1 mm in at least 2 inferior and/or lateral leads (45) is a frequent finding in >20% of ECGs, reflecting late depolarization. Brugada-like ECGs are difficult to interpret because of the overlap between ARVC/D and Brugada syndrome (46–48). Results of Ajmaline testing may be positive in up to 16% of patients with ARVC/D (48), and RV wall motion abnormalities present in 16% of patients with Brugada ECG pattern (47).

    • The role of mutations in the SCN5A gene in cardiomyopathies

      2016, Biochimica et Biophysica Acta - Molecular Cell Research
      Citation Excerpt :

      Brugada syndrome and ARVC are distinct clinical entities, and SCN5A is the only gene common to both. Recent studies have demonstrated that the area of the right ventricular outflow tract (RVOT) was significantly increased, and high intramural signals similar to the fat signal were found in patients with Brugada syndrome [16]. A higher prevalence of SCN5A variants was shown in patients with LVNC with significant arrhythmias than in those with LVNС without arrhythmias [18].

    • Dilated cardiomyopathy and Na<inf>v</inf>1.5

      2014, Cardiac Electrophysiology Clinics
      Citation Excerpt :

      A 24-year-old patient with DCM had significantly increased left ventricular ejection fraction, 24% to 40%, with effective antiarrhythmic treatment (3-year follow-up).25 A 46-year-old proband with significant ventricular dyssynchrony had significantly stabilized heart pumping function (ejection fraction of 52%–55%) after CRT implantation over a 6-year follow-up.20 Another case of myocardial contractile function recovery was described in a patient with DCM, multiple polymorphic premature ventricular contractions and a p.R222Q mutation in SCN5A gene.26

    • Epsilon-like waves and ventricular conduction abnormalities in subjects with type 1 ECG pattern of Brugada syndrome

      2011, Heart Rhythm
      Citation Excerpt :

      Corrado et al6 have shown that a subpopulation of patients with ARVC/D, referred to as concealed forms, presents with the typical clinical and ECG features of BS. In this study, we additionally showed that 1 positive proband for SCN5A gene mutation displayed an epsilon wave, a fact indicating that this ECG marker may not be specific for ARVC/D. Although ARVC/D and BS are definitely distinctive clinical entities, a possible overlap between them could be explained by the hypothesis that BS may start as a primary electrical disease without structural abnormalities and evolve over time to develop mild structural alterations, as observed in the setting of electrical remodeling during permanent atrial fibrillation or hibernating myocardium.15,31 A variety of both antiarrhythmic and nonantiarrhythmic agents have been associated with adverse events in BS patients.32

    View all citing articles on Scopus
    View full text